# Long-Term Specified Drug Use-results Survey of Betanis Tablets

> **NCT01901120** · — · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 1263 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Betanis

## Key facts

- **NCT ID:** NCT01901120
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 1263 (ACTUAL)
- **Last updated:** 2016-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01901120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01901120, "Long-Term Specified Drug Use-results Survey of Betanis Tablets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01901120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*